SCHEMBL7112848

SCHEMBL7112848

C[C](C)OC1CCCCO1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27431134 1.00 MEN1 (0.33) MEN1KMT2A
SCHEMBL7111645 0.93
SCHEMBL12118788 0.83 TSHR (0.40) MEN1KMT2A
SCHEMBL567667 0.83 TSHR (0.40) MEN1KMT2A
SCHEMBL8012777 0.83 MEN1 (0.31) MEN1KMT2A
SCHEMBL3839822 0.77 MEN1 (0.34) MEN1KMT2A
SCHEMBL219412 0.77 ALDH1A1 (0.40) MEN1KMT2A
SCHEMBL2739848 0.76
SCHEMBL390230 0.76 MEN1 (0.32) MEN1KMT2A
SCHEMBL28647211 0.76 MEN1 (0.38) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586644-B2 Reacting aldehyde compound and terminal acetylene in presence of optically active amino alcohol, using tertiary amine and zinc halogenated lower alkane sulfonate as catalyst Carreira, Erick M. (CH) 2003-07-01 US claimed
US-20030088100-A1 Process for producing optically active propargyl alcohols SUMIKA FINE CHEMICALS CO., LTD. 2003-05-08 US claimed
CN-107922379-B Substituted guanidine derivatives 宇部兴产株式会社 2020-11-06 CN disclosed
US-10759781-B2 Substituted guanidine derivatives UBE INDUSTRIES, LTD. (JP) 2020-09-01 US disclosed
US-20190152953-A1 SUBSTITUTED GUANIDINE DERIVATIVES UBE INDUSTRIES, LTD. (JP) 2019-05-23 US disclosed
EP-3333163-A1 SUBSTITUTED GUANIDINE DERIVATIVE UBE Industries, Ltd. (JP) 2018-06-13 EP disclosed
US-6586644-B2 Reacting aldehyde compound and terminal acetylene in presence of optically active amino alcohol, using tertiary amine and zinc halogenated lower alkane sulfonate as catalyst Carreira, Erick M. (CH) 2003-07-01 US disclosed
US-20030088100-A1 Process for producing optically active propargyl alcohols SUMIKA FINE CHEMICALS CO., LTD. 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088100-A1 Process for producing optically active propargyl alcohols ADH1A, ADH1C, ADH5 MEN1 4339/4885KMT2A 1721/4885
US-10759781-B2 Substituted guanidine derivatives GMPS, GUCY1A1, GUCY1A2 MEN1 1957/4885KMT2A 2982/4885
US-20190152953-A1 SUBSTITUTED GUANIDINE DERIVATIVES GMPS, GUCY1A1, GUCY1A2 MEN1 1957/4885KMT2A 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.